Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/00332828.2022.2115279 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Objectives: Calls to action within pharmacy education are frequently seen in the literature, with little information about their authors, audience, and focus, especially whether these calls led to any changes. This scoping review aims to (1) quantitatively and qualitatively characterize the calls to action in pharmacy education and (2) examine the traits of the published articles typically associated with effective advocacy.
Findings: A systematic literature search for scoping review was conducted using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Article Synopsis
- ADHD is a treatable condition, but children from racial-ethnic minority backgrounds often face barriers to timely and consistent treatment.
- Understanding the effects of systemic racism on healthcare can help improve ADHD care for these families.
- The experiences of families of color, along with guidance from healthcare professionals, can inform better clinical practices and foster equitable treatment for ADHD.
Comment on: Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis: a nested case-control study in Sweden.
Eur Respir J
January 2025
Assistance Publique Hôpitaux Paris (AP-HP), Hôpital Bichat, Département de Médecine Interne, Paris, France
Response to the commentary on "Cutaneous rosai-dorfman disease: a systematic review and reappraisal of its treatment and prognosis".
Arch Dermatol Res
December 2024
Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia.
Treating asymptomatic follicular lymphoma: What is the score?
Br J Haematol
December 2024
Department of Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
Health-related quality of life measures are underemphasised in clinical trials and particularly valuable in follicular lymphoma as some interventions can result in substantial toxicity with uncertain impact on overall survival. The report by Marzolini and colleagues provides a nuanced discussion on the merits of rituximab monotherapy versus observation in asymptomatic follicular lymphoma patients. Commentary on: Hou et al.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!